Reading this on a mobile device? Try our optimized mobile version here:

December 4, 2012
Sign upForwardArchiveAdvertise
News for nuclear medicine and molecular imaging professionals
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at

  Top Story 
  • Studies: FLT-PET improves glioma tracking
    A study published in the Journal of Nuclear Medicine that used PET imaging with F-18 fluorothymidine found that FLT uptake corresponded more strongly with the reproduction mechanism in newly diagnosed gliomas compared with recurrent gliomas. The method gave a more comprehensive picture of tumor grade, the study said. Another study published in the same journal that used FLT-PET imaging in patients with high-grade glioma found the signal-to-background ratio for an adaptive threshold delineation method demonstrated better correlation with overall survival than maximum standardized uptake value or other PET segmentation methods used to determine tumor proliferation volume. The method may help improve treatment decisions, researchers said. (free registration) (12/3) LinkedInFacebookTwitterEmail this Story
Your initiatives. Our technology. Together, we can reduce radiation exposure.
Utilizing a fully shielded, mobile design, the MEDRAD™ Intego™ enables sites to infuse doses-on-demand from a multi-dose vial, providing clinicians with added protection and more accurate, repeatable, patient-specific dosing. Click here to learn more.
  Clinical News & Research 
  • MET-PET/CT boosts myeloma lesion, adenoma diagnosis
    A study presented at a radiology meeting found that the mean maximum standardized uptake value with carbon-11 methionine-PET/CT and FDG-PET/CT varied significantly between typical adenomas and normal glands and between atypical and typical adenomas. The findings indicate that both imaging methods can yield useful data to diagnose pituitary adenomas and help predict the likelihood of atypical adenoma prior to surgery. Another study presented at the same meeting found that MET-PET/CT had a higher sensitivity and accuracy than FDG-PET/CT in detecting multiple myeloma lesions, but the two methods had the same specificity. MET-PET/CT can be helpful in cases when FDG-PET/CT results come out as inconclusive or negative, researchers said. (free registration) (12/3) LinkedInFacebookTwitterEmail this Story
  • PET, MRI yield clues on pain experience in fibromyalgia
    Researchers using functional MRI and PET with [11C]carfentanil found that in women with fibromyalgia who were opioid-naive, "changes in functional imaging outcomes were negatively associated with changes in clinical pain." The findings suggest that fibromyalgia pain may be resulting from endogenous opioid-induced hyperalgesia and that patients who manifest changes in the opioid receptor system may have a lower chance of responding to classical exogenous opioids such as codeine and morphine, according to researchers, who reported their findings at a rheumatology meeting. Healio (12/3) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  News from the Field 
  • Survey: Women who have dense breasts OK with more screening
    Most women with dense breast tissue have shown interest in additional screening tests, even with the chance of false positives, extra costs and invasive procedures, according to results from a survey presented at a radiology meeting. Additional screening tests include whole-breast ultrasound and contrast-enhanced mammography. The survey involved 105 women having a routine mammography. (free registration) (12/3) LinkedInFacebookTwitterEmail this Story
  Health Policy 
  • FDA creates collaborative partnership with medical device makers
    The FDA and medical device makers formed a nonprofit organization, the Medical Device Innovation Consortium, to work with one another and with patient advocacy groups, CMS, foundations and academia to speed device approvals while protecting patients. "I know there will be real advances and new approaches that will emerge from it," said FDA Commissioner Dr. Margaret Hamburg. Medtronic, Boston Scientific, Becton Dickinson, Abiomed and Cyberonics are among the medical device companies participating in the consortium. Reuters (12/3) LinkedInFacebookTwitterEmail this Story
  • Cost of 1-year SGR fix increases by $7 billion, CBO says
    The Congressional Budget Office said a one-year fix of Medicare's sustainable growth rate formula for 2013, to stop a 26.5% physician pay cut, will cost $25 billion -- $7 billion more than earlier estimated. American Medical Association President Dr. Jeremy Lazarus said a short-term approach to put off cuts will not work to fix the flawed SGR formula, which should be eliminated. American Medical News (free content) (12/3) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  • ACA to boost claims data managed, overseen by CMS
    CMS expects an increase in the Medicare and Medicaid data that it manages when the Affordable Care Act is fully implemented in 2015. By that year, data related to Medicare claims could nearly double and reach 700 terabytes, while Medicaid claims information could more than triple to 100 terabytes. The agency is focusing its efforts on using enterprise and shared services as well as developing the capabilities needed to gather, assess and leverage real-time data to address the challenge. Healthcare IT News (11/30) LinkedInFacebookTwitterEmail this Story
  From SNMMI 
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

It is astonishing what force, purity and wisdom it requires for a human being to keep clear of falsehoods."
--Margaret Fuller,
American journalist and women's rights activist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Account Director:   Meryl Harold   (202) 407-7828
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.®  Legal Information